Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.36 |
| ▸ | F9 | P00740 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.33 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17247144 | 0.99 | CYP1A1 (0.43) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL17247170 | 0.96 | CYP1A1 (0.41) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL17247164 | 0.95 | CYP1A1 (0.42) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL19082277 | 0.93 | CYP1A1 (0.40) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL17247145 | 0.92 | CYP1A1 (0.41) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL19082252 | 0.92 | CYP1A1 (0.40) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL17247208 | 0.91 | CYP1A1 (0.43) | CYP1A1CYP1B1ALOX5CYP1A2CA12 | |
| SCHEMBL17247147 | 0.91 | CYP1A1 (0.48) | CYP1A1CYP1B1ALOX5CYP1A2MCL1 | |
| SCHEMBL17247162 | 0.91 | CYP1A1 (0.48) | CYP1A1CYP1B1ALOX5CYP1A2MCL1 | |
| SCHEMBL17246872 | 0.91 | CYP1A1 (0.48) | CYP1A1CYP1B1ALOX5CYP1A2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | CYP1A1 399/4885CYP1B1 341/4885ALOX5 4115/4885 |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | CYP1A1 61/4885CYP1B1 276/4885ALOX5 1507/4885 |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | CYP1A1 61/4885CYP1B1 276/4885ALOX5 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.